“Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine”. Clinical Pharmacokinetics48 (8): 543–554. (1 August 2009). doi:10.2165/11317180-000000000-00000. PMID19705924.
“An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria”. Expert Review of Clinical Immunology8 (1): 33–41. (1 January 2012). doi:10.1586/eci.11.87. PMID22149338.
“Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine”. Clinical Pharmacokinetics48 (8): 543–554. (1 August 2009). doi:10.2165/11317180-000000000-00000. PMID19705924.
“An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria”. Expert Review of Clinical Immunology8 (1): 33–41. (1 January 2012). doi:10.1586/eci.11.87. PMID22149338.